Thieme E-Books & E-Journals -
Klinische Pädiatrie, Table of Contents
Klin Padiatr 2020; 232(03): e8-e9
DOI: 10.1055/s-0040-1709805
Abstracts

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Authors

  • S Zeuner

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    3   Medical Faculty, Heidelberg University, Heidelberg

  • J Ecker

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    2   Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg
    4   KiTZ Clinical Trial Unit (ZIPO), University Hospital, Department of Pediatric Hematology and Oncology, Heidelberg

  • J Vollmer

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    3   Medical Faculty, Heidelberg University, Heidelberg

  • S Oppermann

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    2   Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg

  • I Oehme

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    2   Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg

  • H Peterziel

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    2   Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg

  • D ElHarouni

    5   Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg

  • T Hielscher

    6   Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany

  • O Witt

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    2   Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg
    4   KiTZ Clinical Trial Unit (ZIPO), University Hospital, Department of Pediatric Hematology and Oncology, Heidelberg

  • T Milde

    1   Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg
    2   Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg
    4   KiTZ Clinical Trial Unit (ZIPO), University Hospital, Department of Pediatric Hematology and Oncology, Heidelberg
eRefRecommend Article